Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HEL/BIOBV stock hub

HEL/BIOBV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HEL/BIOBVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

36.2M

Nasdaq Helsinki

Market data

Price

Recent price action with selectable time range.

HEL/BIOBVHEL/BIOBV

—

Loading chart…

In the news

Latest news · HEL/BIOBV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/E13.2

P25 n/aP50 n/aP75 n/a

ROE20.2

P25 n/aP50 n/aP75 n/a

ROIC24.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HEL/BIOBV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

EUR

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	FI
Employees	46
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 32.9M
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	FI0009005482
Last refreshed	2026-05-10
Market cap	EUR 36.2M
Price	EUR 2.38
Price currency	EUR
Rev Per Employee	342,000x
Sector	Healthcare
Sic	3821
Symbol	hel/BIOBV
Website	https://www.biohithealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.57%
EV Earnings	12.03x
EV/EBIT	10.79x
EV/EBITDA	9.5x
EV/FCF	-24.16x
EV/Sales	2.09x
FCF yield	-3.77%
Forward P/E	15.87x
P/B ratio	2.42x
P/E ratio	13.22x
P/S ratio	2.3x
PE Ratio10 Y	22.92x
PE Ratio3 Y	17.29x
PE Ratio5 Y	17.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.4%
EBITDA Margin	19.91%
Gross margin	68.33%
Gross Profit	EUR 10.7M
Gross Profit Growth	11.52%
Gross Profit Growth Q	23.42%
Gross Profit Growth3 Y	7.87%
Gross Profit Growth5 Y	8.31%
Net Income	EUR 2.7M
Net Income Growth	6.62%
Net Income Growth Q	34.36%
Net Income Growth Quarters	1%
Net Income Growth Years	5%
Net Income Growth3 Y	18.37%
Net Income Growth5 Y	19.99%
Pretax Margin	18.44%
Profit Margin	17.4%
Profit Per Employee	EUR 59,522
Profitable Years	4
ROA	10.8
Roa5y	5.84
ROCE	18.85
ROE	20.18
Roe5y	11.05
ROIC	24.67
Roic5y	22.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.23%
Cagr15y	2.34%
Cagr1y	-10.53%
Cagr20y	2.42%
Cagr3y	8.56%
Cagr5y	1.87%
EPS Growth	6.27
EPS Growth Q	32.55
EPS Growth Quarters	1
EPS Growth Years	5
EPS Growth3 Y	18.15
EPS Growth5 Y	20.76
FCF Growth Q	-92.73%
OCF Growth Q	-73.54%
Revenue Growth	10.15x
Revenue Growth Q	21.05x
Revenue Growth Quarters	1x
Revenue Growth Years	5x
Revenue Growth3 Y	4.02x
Revenue Growth5 Y	6.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.89
Assets	EUR 19.8M
Cash	EUR 4.9M
Current Assets	EUR 9.2M
Current Liabilities	EUR 3.6M
Debt	EUR 1.6M
Debt EBITDA	EUR 0.46
Debt Equity	EUR 0.11
Debt FCF	EUR -1.17
Equity	EUR 14.9M
Interest Coverage	67.82
Liabilities	EUR 4.9M
Long Term Assets	EUR 10.6M
Long Term Liabilities	EUR 1.3M
Net Cash	EUR 3.3M
Net Cash By Market Cap	EUR 9.01
Net Cash Growth	-46.72%
Net Debt EBITDA	EUR -1.04
Net Debt Equity	EUR -0.22
Tangible Book Value	EUR 14.3M
Tangible Book Value Per Share	EUR 0.94
WACC	7.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.56
Inventory Turnover	5.45
Net Working Capital	EUR 1.1M
Quick ratio	2.34
Working Capital	EUR 5.6M
Working Capital Turnover	EUR 2.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.09%
Dividend per share	EUR 0
Last Dividend	EUR 0.72

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.78%
1Y total return	-10.53%
200-day SMA	2.95
3Y total return	27.96%
50-day SMA	2.43
50-day SMA vs 200-day SMA	50under200
5Y total return	9.68%
All Time High	9.1
All Time High Change	-73.85%
All Time High Date	2013-01-14
All Time Low	0.74
All Time Low Change	222.67%
All Time Low Date	2003-03-04
ATR	0.14
Beta	0.56
Beta1y	-0.18
Beta2y	-0.16
Ch YTD	-35.5
High	2.52
High52	3.78
High52 Date	2025-12-12
High52ch	-37.04%
Low	2.35
Low52	2.2
Low52 Date	2026-03-31
Low52ch	8.18%
Ma50ch	-2.14%
Price vs 200-day SMA	-19.24%
RSI	41.61
RSI Monthly	46.22
RSI Weekly	37.61
Sharpe ratio	-0.19x
Sortino ratio	-0.14
Total Return	-1.09%
Tr YTD	-35.5
Tr15y	41.52%
Tr1m	7.69%
Tr1w	-6.3%
Tr3m	-28.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.1M
Operating Income Growth	24.22
Operating Income Growth Q	47.33
Operating Income Growth3 Y	20.95
Operating Income Growth5 Y	22.03
Operating margin	19.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,501,177%
Net Borrowing	-302,000
Shares Insiders	40.21%
Shares Institutions	1.47%
Shares Out	15,205,593
Shares Qo Q	2.62%
Shares Yo Y	1.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.4M
Average Volume	10,656.75x
Bv Per Share	0.98
CAPEX	EUR -615,000
Ch10y	-52.78
Ch15y	-16.49
Ch1m	7.69
Ch1w	-6.3
Ch1y	-10.53
Ch20y	-4.8
Ch3m	-28.74
Ch3y	27.96
Ch5y	9.68
Ch6m	-22.22
Change	-2.86%
Change From Open	-2.86
Close	2.45
Days Gap	0
Depreciation Amortization	81,000
Dollar Volume	34,310.1
Earnings Date	2026-08-05
EBIT	EUR 3.1M
EBITDA	EUR 3.1M
EPS	EUR 0.18
F Score	3
FCF	EUR -1.4M
FCF EV Yield	-4.14x
FCF Per Share	EUR -0.09
Financing CF	-286,000
Fiscal Year End	December
Founded	1,988
Graham Number	1.99526
Graham Upside	-16.17
Income Tax	EUR 163,000
Investing CF	874,000
Is Primary Listing	1
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Lynch Fair Value	EUR 3.6
Lynch Upside	51.15
Ma150	2.97
Ma150ch	-19.89%
Ma20	2.52
Ma20ch	-5.56%
Net CF	-207,000
Next Earnings Date	2026-08-05
Open	2.45
Position In Range	17.65
Ppne	1,856,000
Price Date	2026-05-08
Price EBITDA	EUR 11.55
Ptbv Ratio	2.53
Relative Volume	1.43x
Revenue	15,732,000x
Tax By Revenue	1.04x
Tax Rate	5.62%
Tr20y	61.33%
Tr6m	-22.22%
Volume	14,416
Z Score	7.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HEL/BIOBV pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/BIOBV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HEL/BIOBV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.5%

Share of float held by funds and institutions

Insider ownership

+40.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.1%

Negative means the company is buying back shares.

Technical

HEL/BIOBV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-19.2%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

-0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HEL/BIOBV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/BIOBV stock rating?

hel/BIOBV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/BIOBV analysis?

The full report lives at /stocks/hel/BIOBV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/BIOBV?

The latest report frames hel/BIOBV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/BIOBV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.